BC
Bachem Holding AG
BCHMF · OTC
$91.23 +0.25% (+$0.23)
Market Cap CHF 5.62B
P/E Ratio 37.78x
Div. Yield 0.63%
ROE 10.55%
Bulios Fair Price
$55.95
38.7% downside
Current Price
$91.23
Undervalued Fair Value Overvalued
According to Bulios Fair Price, BCHMF is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
5/9Valuation
19 /100
Expensive P/B 3.85x
P/S 8.09x
P/E 37.78x
Growth
68 /100
Growing Rev. growth 9.36%
Book val. growth 7.65%
EPS growth 13.06%
Profitability
57 /100
Moderate FCF margin 6.93%
Op. margin 21.62%
Gross margin 28.74%
Quality
46 /100
Average Asset turnover 0.33x
ROA 7.06%
ROIC 8.12%
Debt
99 /100
Low Net debt/EBITDA 0.14x
Int. coverage 310.51x
Debt/Equity 0.04x
Stability
100 /100
Stable Profitable years 6
EPS volatility 9.16%
Beta 0.81x
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about BCHMF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Anne-Kathrin Stoller
Employees
2,511
Headquarters
Bubendorf
Upcoming events
04 MAR
Earnings
Upcoming earnings report